EDENOR Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated April 18, 2008, reports on the General Ordinary and Extraordinary Shareholders meeting held by EDENOR (Empresa Distribuidora y Comercializadora Norte S.A.) on April 15, 2008, in Buenos Aires, Argentina. The filing details resolutions passed regarding the approval of 2007 financial statements, board composition, auditor appointments, and debt authorization.
Key Financial Metrics
| Metric | Value (USD) | Period |
|---|---|---|
| Net Income | 122,458,766.46 | Year ended Dec 31, 2007 |
| Shareholders' Equity | 1,974,581,430.57 | As of Dec 31, 2007 |
| Unassigned Results (Negative Balance) | (88,609,973.42) | As of Dec 31, 2007 |
| Share Premium | 106,927,702.83 | As of Dec 31, 2007 |
| Directors' Fees | 1,064,485.00 | Year ended Dec 31, 2007 |
| Fiscal Committee Fees | 87,500.00 | Year ended Dec 31, 2007 |
| 2007 Audit Fees (Deloitte) | 432,500.00 | Year ended Dec 31, 2007 |
| 2008 Audit Fees (PwC) | 540,000.00 | Approved for 2008 |
The filing does not provide specific data on revenue, operating margins, cash flow, or total debt levels for the period.
Material Changes and Corporate Actions
- Board Composition: Eduardo L. Llanos was elected to the Board of Directors, replacing outgoing Director Alfredo MacLaughlin.
- Auditor Change: The company switched auditors from Estudio Deloitte & Co. S.R.L. to Price Waterhouse & Co. S.R.L. (Daniel Alejandro López and Carlos Martín Barbafina) for the 2008 fiscal year.
- Equity Adjustment: Shareholders approved the absorption of a negative unassigned results balance of $88.6 million into the share premium account.
- Debt Authorization: The Board was granted authority to execute a global debt program, including setting terms, soliciting public offers, and listing debt on various exchanges.
Outlook, Risks, and Management Commentary
The filing contains no specific forward-looking guidance, revenue outlook, or management commentary regarding operational risks or market conditions. The primary focus is on the ratification of past financial performance and the authorization of future debt issuance capabilities.
Investor Verification Checklist
- Verify the impact of the auditor change from Deloitte to Price Waterhouse on future financial reporting consistency.
- Review the terms and conditions of the newly authorized global debt program to assess leverage implications.
- Confirm the treatment of the $88.6 million negative unassigned results absorption in the balance sheet.
- Monitor the composition of the Board of Directors following the appointment of Eduardo L. Llanos.